APO-FLUPHENAZINE INJECTABLE 25 MG
FLUPHENAZINE DECANOATE : 25 MG · DIN 02244166 · APOTEX INC
Health Canada status: CANCELLED POST MARKET
What is APO-FLUPHENAZINE INJECTABLE?
APO-FLUPHENAZINE INJECTABLE 25 MG contains FLUPHENAZINE DECANOATE : 25 MG. It is listed in the Health Canada Drug Product Database under DIN 02244166, held by APOTEX INC, supplied as LIQUID for INTRAMUSCULAR ; SUBCUTANEOUS administration. Health Canada currently lists it as cancelled post market, status dated 02-Aug-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is APO-FLUPHENAZINE INJECTABLE called?
The same molecule, FLUPHENAZINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Modecate | Latin | Morocco, South Africa |
| FLUPHENAZINE HCl | Latin | Lebanon |
| MODITEN | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02244166 |
|---|---|
| Brand name | APO-FLUPHENAZINE INJECTABLE |
| Generic / active ingredient | FLUPHENAZINE DECANOATE : 25 MG |
| Manufacturer | APOTEX INC |
| Strength | 25 MG |
| Dosage form | LIQUID |
| Route of administration | INTRAMUSCULAR ; SUBCUTANEOUS |
| Schedule | Prescription |
| ATC code | N05AB02 FLUPHENAZINE |
| AHFS class | 28:16.08.24 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 02-Aug-2013 |
| Original market date | 2001-10-05 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02244166 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2244166 |
| Brand name | APO-FLUPHENAZINE INJECTABLE |
| Active ingredient / INN | FLUPHENAZINE DECANOATE : 25 MG |
| ATC code | N05AB02 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N05 |
| AHFS class | 28:16.08.24 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | APOTEX INC |
Which pack is which?
| Strength on the label | 25 MG |
|---|---|
| Dosage form | LIQUID |
| Route | INTRAMUSCULAR ; SUBCUTANEOUS |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Is FLUPHENAZINE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by AA PHARMA INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N05AB02 FLUPHENAZINE. 3 of 25 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLUPHENAZINE | 1 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00405345 |
| FLUPHENAZINE | 2 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00410632 |
| FLUPHENAZINE | 5 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00405361 |
| APO FLUPHENAZINE TAB 2.5MG | 2.5 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00405353 |
| FLUPHENAZINE 1 TAB 1MG | 1 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00563846 |
| FLUPHENAZINE 2 TAB 2MG | 2 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00563838 |
| FLUPHENAZINE 5 TAB 5MG | 5 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00563803 |
| FLUPHENAZINE DECANOATE INJECTION B.P. | 100 MG | LIQUID | HOSPIRA HEALTHCARE ULC | CANCELLED PRE MARKET | DIN 02189097 |
| FLUPHENAZINE DECANOATE INJECTION B.P. | 25 MG | LIQUID | HOSPIRA HEALTHCARE ULC | CANCELLED PRE MARKET | DIN 02189089 |
| FLUPHENAZINE DECANOATE INJECTION, USP | 25 MG | SOLUTION | MYLAN PHARMACEUTICALS ULC | CANCELLED PRE MARKET | DIN 02383225 |
How much does FLUPHENAZINE cost around the world?
FLUPHENAZINE is listed on 4 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Lebanon publishes a public price (USD, Decision 119/1); Morocco publishes a PPV (public price); South Africa publishes a single exit price. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 4 | 77 | USD███.██ |
| South Africa | single exit price | 1 | 3 | ZAR███.██ |
| Morocco | PPV (public price) | 2 | 2 | MAD███.██ |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | USD███.██ |
83 pack listings across 8 brand entries and 4 price bases, refreshed 05 Sep 2026. Ranges span every FLUPHENAZINE pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.